1 reports of this reaction
1.2% of all PYRANTEL PAMOATE reports
#14 most reported adverse reaction
BRONCHITIS is the #14 most commonly reported adverse reaction for PYRANTEL PAMOATE, manufactured by REESE PHARMACEUTICAL CO.. There are 1 FDA adverse event reports linking PYRANTEL PAMOATE to BRONCHITIS. This represents approximately 1.2% of all 83 adverse event reports for this drug.
Patients taking PYRANTEL PAMOATE who experience bronchitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BRONCHITIS is a less commonly reported adverse event for PYRANTEL PAMOATE, but still significant enough to appear in the safety profile.
In addition to bronchitis, the following adverse reactions have been reported for PYRANTEL PAMOATE:
The following drugs have also been linked to bronchitis in FDA adverse event reports:
BRONCHITIS has been reported as an adverse event in 1 FDA reports for PYRANTEL PAMOATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BRONCHITIS accounts for approximately 1.2% of all adverse event reports for PYRANTEL PAMOATE, making it a notable side effect.
If you experience bronchitis while taking PYRANTEL PAMOATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.